- Home
- OHI vs ROIV Comparison
OHI vs ROIV Comparison
Compare OHI & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OHI
- ROIV
- Stock Information
- Founded
- OHI 1992
- ROIV 2014
- Country
- OHI United States
- ROIV United Kingdom
- Employees
- OHI N/A
- ROIV N/A
- Industry
- OHI Real Estate Investment Trusts
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- OHI Real Estate
- ROIV Health Care
- Exchange
- OHI Nasdaq
- ROIV Nasdaq
- Market Cap
- OHI 10.2B
- ROIV 8.4B
- IPO Year
- OHI N/A
- ROIV N/A
- Fundamental
- Price
- OHI $37.68
- ROIV $11.27
- Analyst Decision
- OHI Buy
- ROIV Strong Buy
- Analyst Count
- OHI 12
- ROIV 8
- Target Price
- OHI $38.45
- ROIV $17.93
- AVG Volume (30 Days)
- OHI 1.9M
- ROIV 5.1M
- Earning Date
- OHI 02-05-2025
- ROIV 02-11-2025
- Dividend Yield
- OHI 7.15%
- ROIV N/A
- EPS Growth
- OHI 40.81
- ROIV N/A
- EPS
- OHI 1.36
- ROIV 5.89
- Revenue
- OHI $1,011,391,000.00
- ROIV $129,128,999.00
- Revenue This Year
- OHI N/A
- ROIV $15.98
- Revenue Next Year
- OHI $9.06
- ROIV N/A
- P/E Ratio
- OHI $27.62
- ROIV $1.91
- Revenue Growth
- OHI 18.25
- ROIV 145.68
- 52 Week Low
- OHI $27.53
- ROIV $9.69
- 52 Week High
- OHI $44.42
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- OHI 46.51
- ROIV 46.46
- Support Level
- OHI $37.08
- ROIV $10.89
- Resistance Level
- OHI $37.89
- ROIV $11.26
- Average True Range (ATR)
- OHI 0.79
- ROIV 0.36
- MACD
- OHI 0.09
- ROIV -0.02
- Stochastic Oscillator
- OHI 69.88
- ROIV 47.75
About OHI Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.